Last updated on December 2018

Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome


Brief description of study

The study aim is to investigate the efficacy and safety of Osilodrostat in patients with Cushing's syndrome due to causes other than Cushing's disease in Japan.

Clinical Study Identifier: NCT02468193

Contact Investigators or Research Sites near you

Start Over

Novartis Pharmaceuticals

Novartis Investigative Site
Fukuoka city, Japan

Novartis Pharmaceuticals

Novartis Investigative Site
Fukushima-city, Japan

Novartis Pharmaceuticals

Novartis Investigative Site
Kobe-city, Japan

Novartis Pharmaceuticals

Novartis Investigative Site
Nishinomiya-city, Japan

Novartis Pharmaceuticals

Novartis Investigative Site
Yokohama, Japan

Novartis Pharmaceuticals

Novartis Investigative Site
Sendai-city, Japan

Novartis Pharmaceuticals

Novartis Investigative Site
Chiba, Japan

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.